Pre-Submission Review for Genetics and Genomics Papers: What Nature Genetics Reviewers Expect

Identifying an associated locus is no longer sufficient for top genetics journals. Reviewers expect:

• computational fine-mapping to identify candidate causal variants
• eQTL or chromatin accessibility data linking variants to gene expression changes
• functional experiments validating the biological mechanism (CRISPR perturbation, reporter assays, animal models)
• integration with single-cell data where relevant

A paper that reports 50 new GWAS loci without any functional follow-up will face desk rejection at Nature Genetics. The editorial bar now includes mechanism, not just association.

Genetics has specific statistical conventions that reviewers check carefully:

• genome-wide significance thresholds (5 x 10^-8 for GWAS) applied and justified
• multiple testing corrections appropriate for the analysis type
• population stratification addressed (principal components, mixed models)
• linkage disequilibrium structure accounted for in fine-mapping
• heritability estimates reported with appropriate methods (GREML, LDSC)
• Mendelian randomization assumptions tested (if used)

• genome-wide significant loci reported with correct significance threshold
• population stratification corrected (method specified)
• replication in an independent cohort (or justification for discovery-only)
• fine-mapping attempted for top loci
• functional annotation of candidate variants (eQTL, chromatin data)
• ancestry composition of the cohort described clearly
• GWAS summary statistics made available (or access mechanism described)
• Manhattan and QQ plots presented
• sample size adequate for the effect sizes being reported

• variant pathogenicity classified using ACMG/AMP criteria
• segregation data presented when available
• functional validation of variants (in vitro or computational)
• phenotype-genotype correlation described
• population frequency of variants reported (gnomAD, TopMed)

• benchmarking against existing methods on standard datasets
• runtime and memory requirements documented
• software publicly available with documentation
• simulated and real data used for validation
• limitations clearly described

• data deposited in appropriate repositories (dbGaP, EGA, GEO)
• code deposited in public repository with DOI
• reporting checklist completed (STREGA for genetic association studies)
• ethical approvals documented (especially for human genetic data)

In our pre-submission review work, genetics papers most often get overestimated when a statistically strong result is treated as if it already answers the editorial question. Reviewers still want to know whether the signal generalizes, whether the mechanism is plausible, and whether the journal target expects more functional depth than the draft can currently support.

Our review of current genetics author guidance points in the same direction. Multi-ancestry framing, replication logic, and methods transparency are no longer optional polish for ambitious submissions. They shape whether the manuscript reads like a durable genetics contribution or just a large dataset with interesting associations.

The manuscript readiness check evaluates methodology, citation integrity, and journal fit in about 1-2 minutes. For genetics manuscripts, citation verification catches missing references to recent competing studies (large biobank studies, updated reference panels, or methodological advances).

The manuscript readiness check provides journal-specific calibration, which is important because Nature Genetics, American Journal of Human Genetics, and PLOS Genetics have very different editorial standards.

For manuscripts targeting Nature Genetics, Manusights Expert Review ($1,000 to $1,800) connects you with genetics reviewers who know what that journal's editors currently prioritize.

Genetics papers often become vulnerable when authors interpret association strength as submission readiness. Reviewers in this area know that statistical significance, biological meaning, and editorial significance are different thresholds.

That is why pre-submission review helps. It should tell the author whether the manuscript already reads like a credible genetics contribution for the intended journal, or whether it still needs stronger functional grounding, clearer ancestry framing, or a more realistic target before submission.

Many genetics manuscripts get most of the hard work right and still stall because the editorial story is not complete. The association is significant, the cohort is large, and the plots are polished, but the manuscript still leaves the reader uncertain about biological meaning, portability across ancestries, or whether the signal changes understanding in a way the target journal really cares about.

That is the late-stage problem pre-submission review can solve. It should expose whether the paper already reads as a full genetics contribution or whether it is still a strong dataset waiting for sharper interpretation and a better-matched venue.

Use this final check before submission:

• identify the strongest locus, variant, or method claim in the paper
• ask what evidence on the page makes that claim feel biologically or methodologically consequential rather than merely statistically significant
• decide whether the current journal target expects more replication, more functional depth, or simply a narrower framing

That exercise usually clarifies the next move faster than more incremental polishing. It tells the author whether to submit now, strengthen the mechanism case, or reposition the manuscript around the contribution it can defend most credibly.

In practice, that saves authors from the common mistake of treating one more association table or one more polishing pass as if it solved an editorial readiness problem. Often the real fix is a sharper statement of what the manuscript can truly claim, for whom, and at what journal tier.

That clarity usually matters more than incremental presentation polish.